Loading clinical trials...
Loading clinical trials...
This is an extension study of REACT-FM. The primary objective of the study is to assess the response to digital therapy in the treatment of fibromyalgia over an additional 9 months.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Swing Therapeutics, Inc.
NCT07425652 · Fibromyalgia
NCT07642882 · Fibromyalgia, Depression - Major Depressive Disorder, and more
NCT07614945 · Fibromyalgia
NCT07226648 · Fibromyalgia
NCT07483216 · Fibromyalgia (FM)
Swing Therapeutics
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions